Get started
Author

Vishwa M. Shah

Observed name: Vishwa Shah
ORCID: 0000-0002-0433-2737
Observed ORCID: 0000-0002-0433-2737
OpenAlex ID: A5012383090
Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy
2025 · Andres Portocarrero-Bonifaz, Salman Syed, et al. · PLoS ONE · 5
PDF
Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy
2024 · Andres Portocarrero-Bonifaz, Salman Syed, et al. · Brachytherapy · 2
In vivo chemotherapy exposure alters the expression of stemness and epithelial-mesenchymal transition factors in high-grade serous ovarian cancer samples
2025 · Julia Ritchie, Nora Badiner, et al. · Gynecologic Oncology
Percutaneous nephrostomies in gynecologic malignancy can be a pain in the back
2025 · Julia Ritchie, Cynthia Matsumura, et al. · Gynecologic Oncology Reports
A comparison of stemness and epithelial-mesenchymal transition factors in Mullerian carcinosarcoma based on organ of origin
2025 · Vishwa Shah, Julia Ritchie, et al. · Gynecologic Oncology Reports
1953: Dosimetric comparison between different applicators for high dose rate gynecologic brachytherapy
2024 · Andres Portocarrero-Bonifaz, Salman Syed, et al. · Radiotherapy and Oncology
High dose rate interstitial brachytherapy for locally advanced or recurrent vulvar cancer: Methods, prescription doses, toxicities, and outcomes at a single institution (1162)
2023 · Vishwa Shah, Andres Portocarrero Bonifaz, et al. · Gynecologic Oncology
PDF
Works count: 7
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type